Back to Search

KATHRYN KOLIBABA, M.D.

M.D.

Hematology & Oncology Physician

NPI: 1932102720Individual

Specialties, Licenses & Credentials

Hematology & Oncology PhysicianPrimary

Internal Medicine — Hematology & Oncology

Code: 207RH0003X

MD00034066(WA)

Research & Publications (4)

Results of a Phase II trial of gemcitabine, mitoxantrone, and rituximab in relapsed or refractory mantle cell lymphoma.
PMID 18953490·Invest New Drugs·2009
3-trial
Catalytic domains of tyrosine kinases determine the phosphorylation sites within c-Cbl.
PMID 15556646·FEBS Lett·2004
4-observational
CaM kinase IV regulates lineage commitment and survival of erythroid progenitors in a non-cell-autonomous manner.
PMID 11076966·J Cell Biol·2000
7-preclinical
Efficacy of STI571, an abl tyrosine kinase inhibitor, in conjunction with other antileukemic agents against bcr-abl-positive cells.
PMID 11050003·Blood·2000
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
210 SE 136TH AVE
VANCOUVER, WA 98684

Location

Practice Location

210 SE 136TH AVE, VANCOUVER, WA
(360) 944-9889

Quick Facts

NPI
1932102720
Entity Type
Individual
Gender
Female
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
4

Are you this provider?

Claim Your Profile